Literature DB >> 24211540

Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.

Sagnik Chatterjee1, Ingrid T G W Bijsmans2, Saskia W C van Mil3, Patrick Augustijns4, Pieter Annaert5.   

Abstract

Excessive intrahepatic accumulation of bile acids (BAs) is a key mechanism underlying cholestasis. The aim of this study was to quantitatively explore the relationship between cytotoxicity of BAs and their intracellular accumulation in sandwich-cultured rat hepatocytes (SCRH). Following exposure of SCRH (on day-1 after seeding) to various BAs for 24h, glycine-conjugated BAs were most potent in exerting toxicity. Moreover, unconjugated BAs showed significantly higher toxicity in day-1 compared to day-3 SCRH. When day-1/-3 SCRH were exposed (0.5-4h) to 5-100μM (C)DCA, intracellular levels of unconjugated (C)DCA were similar, while intracellular levels of glycine conjugates were up to 4-fold lower in day-3 compared to day-1 SCRH. Sinusoidal efflux was by far the predominant efflux pathway of conjugated BAs both in day-1 and day-3 SCRH, while canalicular BA efflux showed substantial interbatch variability. After 4h exposure to (C)DCA, intracellular glycine conjugate levels were at least 10-fold higher than taurine conjugate levels. Taken together, reduced BA conjugate formation in day-3 SCRH results in lower intracellular glycine conjugate concentrations, explaining decreased toxicity of (C)DCA in day-3 versus day-1 SCRH. Our data provide for the first time a direct link between BA toxicity and glycine conjugate exposure in SCRH.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid; BAAT; BAs; BEI; BSEP/Bsep; Bile acid conjugation; Bile acids; CA; CDCA; Chenodeoxycholic acid; Cholestasis; DMSO; FBS; Fetal Bovine Serum GCDCA, glycochenodeoxycholic acid; GDCA; HBSS; HEPES; Hanks’ Balanced Salt Solution; Hepatotoxicity; NOAEL; NTCP/Ntcp; PBS; Phosphate Buffered Saline; SCH; SCRH; Sandwich-cultured rat hepatocytes; TCDCA; TDCA; bile acid CoA: amino acid N-acyltransferase; bile acids; bile salt export pump (human/rat); biliary excretion index; chenodeoxycholic acid; cholic acid; dimethyl sulfoxide; glycodeoxycholic acid; no observed adverse effect level; sandwich-cultured hepatocytes; sandwich-cultured rat hepatocytes; sodium taurocholate cotransporting polypeptide (human/rat); taurochenodeoxycholic acid; taurodeoxycholic acid

Mesh:

Substances:

Year:  2013        PMID: 24211540     DOI: 10.1016/j.tiv.2013.10.020

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  16 in total

1.  Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Methods Mol Biol       Date:  2015

2.  Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease.

Authors:  James J Beaudoin; Jacqueline Bezençon; Yanguang Cao; Katsuhiko Mizuno; Sharin E Roth; William J Brock; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2018-11-30       Impact factor: 3.922

3.  Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.

Authors:  Erin E Gill; Octavio L Franco; Robert E W Hancock
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

Review 4.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

5.  Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.

Authors:  Qiao-Ling Yang; Fan Yang; Jun-Ting Gong; Xiao-Wen Tang; Guang-Yun Wang; Zheng-Tao Wang; Li Yang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

6.  Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.

Authors:  James J Beaudoin; Jacqueline Bezençon; Noora Sjöstedt; John K Fallon; Kim L R Brouwer
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

7.  PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice.

Authors:  Cindy Yanfei Li; Joseph L Dempsey; Dongfang Wang; SooWan Lee; Kris M Weigel; Qiang Fei; Deepak Kumar Bhatt; Bhagwat Prasad; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2018-05-16       Impact factor: 3.922

8.  Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease.

Authors:  William J Brock; James J Beaudoin; Jason R Slizgi; Mingming Su; Wei Jia; Sharin E Roth; Kim L R Brouwer
Journal:  Int J Toxicol       Date:  2018 Mar/Apr       Impact factor: 2.032

9.  Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury.

Authors:  Jeffrey L Woodhead; Kyunghee Yang; Scott Q Siler; Paul B Watkins; Kim L R Brouwer; Hugh A Barton; Brett A Howell
Journal:  Front Pharmacol       Date:  2014-11-07       Impact factor: 5.810

10.  Hepatocytes maintain greater fluorescent bile acid accumulation and greater sensitivity to drug-induced cell death in three-dimensional matrix culture.

Authors:  John W Murray; Dennis Han; Allan W Wolkoff
Journal:  Physiol Rep       Date:  2014-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.